Find out if you have an Antidepressant lawsuit

Since the late 1990’s, there has been concern over increased risk of suicide in young children and teenagers taking antidepressants. In 2003, it was estimated that nearly ten million antidepressant prescriptions had been written for children and teens under 18.

Per the Food and Drug Administration, all anti-depressant packaging is required to possess a “black box” warning, the strongest safety alert from the government. The label warns patients and their families of the antidepressants’ link to increased suicidal thoughts and behavior among children and teens taking them. Since some physicians have prescribed antidepressants not approved for use in children, it is important that they now revisit the decision to use these products “off-label.”

The antidepressant group of drugs to carry this “black box” warning label include: Anafranil, Aventyl, Celexa, Cymbalta, Desyrel, Effexor, Elavil, Lexapro, Ludiomil, Luvox, Marplan, Nardil, Norpramin, Pamelor, Parnate, Paxil, Pexeva, Prozac, Remeron, Sarafem, Serzone, Sinequan, Surmontil, Symbyax,Tofranil, Tofranil-PM, Triavil, Vivactil, Wellbutrin, Zoloft and Zyban.

In addition, an information guide will be distributed with each of these antidepressant prescriptions. Parents of young patients will be advised to monitor warning signs in children like depression; talking about feeling suicidal or wanting to die; feeling hopeless, like nothing will ever change or get better; feeling helpless, that nothing one does makes any difference; irritability; and strange changes in behavior.

If your child or family member has taken an antidepressant and have experienced any of these symptoms, call our antidepressant injury lawyers now at 1-800-THE-EAGLE (1-800-843-3245) or SUBMIT A SHORT AND SIMPLE CASE FORM HERE.

Let Us Help You Seek Justice

Email us information about your potential claim, or give us a call 24/7 at 1-800-THE-EAGLE (1-800-843-3245) for a free, no obligation consultation.
  • I agree that I am not a client of Goldberg & Osborne for this matter unless I sign a written fee agreement with the Firm.

  • This field is for validation purposes and should be left unchanged.